Health CanadaGeneral Alert
AVASTIN (bevacizumab) - Reports of Cases of Severe Eye Inflammation Leading to B...
Published: December 7, 2011Recall ID: 25508Category: generalCountry: Canada
Product Description & Identification
AVASTIN (bevacizumab) - Reports of Cases of Severe Eye Inflammation Leading to Blindness Following Use in the Eye - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 25508 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/avastin-bevacizumab-reports-cases-severe-eye-inflammation-leading-blindness-0 |
| Title | AVASTIN (bevacizumab) - Reports of Cases of Severe Eye Inflammation Leading to Blindness Following Use in the Eye - For Health Professionals |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2011-12-07 |
| Organization | Marketed health products |